Aurinia Pharmaceuticals (AUPH)
(Delayed Data from NSDQ)
$7.20 USD
0.00 (0.00%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $7.22 +0.02 (0.28%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | 0.02 |
EPS Last Quarter | 0.02 |
Last EPS Surprise | 100.00% |
ABR | 1.57 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.04 |
Next Year | 0.45 |
EPS (TTM) | -0.29 |
P/E (F1) | 180.00 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 56.64M | 70.73M | 235.57M | 288.40M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 57.60M | 71.75M | 237.60M | 306.59M |
Low Estimate | 56.01M | 69.20M | 234.30M | 264.70M |
Year ago Sales | 54.52M | 45.10M | 175.51M | 235.57M |
Year over Year Growth Est. | 3.89% | 56.82% | 34.22% | 22.43% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.02 | 0.11 | 0.04 | 0.45 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | 0.02 | 0.10 | -0.02 | 0.59 |
High Estimate | 0.04 | 0.15 | 0.16 | 0.59 |
Low Estimate | 0.01 | 0.08 | -0.09 | 0.19 |
Year ago EPS | -0.09 | -0.19 | -0.54 | 0.04 |
Year over Year Growth Est. | 122.22% | 157.89% | 107.41% | 1,025.00% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 3 | 2 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.02 | 0.11 | 0.04 | 0.45 |
7 Days Ago | 0.02 | 0.11 | 0.04 | 0.45 |
30 Days Ago | 0.02 | 0.11 | 0.04 | 0.45 |
60 Days Ago | 0.04 | 0.15 | 0.04 | 0.53 |
90 Days Ago | 0.04 | 0.15 | 0.04 | 0.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.02 | 0.11 | 0.04 | 0.45 |
Zacks Consensus Estimate | 0.02 | 0.11 | 0.04 | 0.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.02 | -0.03 | -0.19 | -0.09 | NA |
Estimate | 0.01 | -0.17 | -0.18 | -0.17 | NA |
Difference | 0.01 | 0.14 | -0.01 | 0.08 | 0.06 |
Surprise | 100.00% | 82.35% | -5.56% | 47.06% | 55.96% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more